Public Relations and News

Tel Aviv, Israel (PRWEB) August 26: HealthWatch’s Master Caution® Device has received FDA clearance as a Class II medical device intended to condition electrocardiogram (ECG) signals for digital transmission via Bluetooth technology to smartphones and other remotely.

The CE has approved the HealthWatch Master Caution® Device as a medical device intended to condition electrocardiogram (ECG) signals for digital transmission via Bluetooth technology to smartphones and other remote devices.

HealthWatch’s Master Caution® products are designed to enable continuous 12/15-lead ECG monitoring via textile garments and smartphone applications, with no lifestyle change, no matter where a person may be.

The study was conducted on 15 patients (9 male, 6 female) ranging in age from 31 to 82 and in weight from 70 to 135 kg in which both objective and subjective parameters were recorded.

HealthWatch’s hWear™ — the digital, heart-sensing garment incorporating interwoven textile electrodes – detecting true 3-to-15 lead ECG signals at higher quality than standard ECG electrodes at rest and in motion.

“Unlike other products that report only heart rate, our new healthwear garment is a true medical device monitoring full 15-lead ECGs along with other physiological vital signals. It will change the future of personal...